Related Experiment Videos
Materials and embolic agents for endovascular treatment
M H Khayata1, B L Dean, R F Spetzler
1Barrow Neurological Institute, Division of Neurological Surgery, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Neurosurgery Clinics of North America
|July 1, 1994
Summary
Advancements in intravascular techniques and neurophysiology have improved treatment for vascular issues. The focus is now on specific embolic agents for closing fistulas, obliterating malformations, and filling aneurysms.
Area of Science:
- Neurology
- Interventional Radiology
- Biomaterials Science
Background:
- Intravascular techniques have significantly evolved, driven by new material development and enhanced understanding of neurophysiology.
- Improved access has shifted the focus from overcoming limitations to effectively treating neurovascular pathologies.
Purpose of the Study:
- To highlight the advancements in embolic materials and their targeted applications in neurovascular interventions.
- To emphasize the shift in focus from general toxicity and dose-response studies to specific indications for embolic agents.
Main Methods:
- Review of current literature on embolic materials and intravascular techniques.
- Analysis of the changing landscape of embolic agent selection based on specific clinical indications.
- Discussion of the impact of neurophysiology understanding on procedural success.
Main Results:
- Embolic materials have diversified, offering tailored solutions for various neurovascular conditions.
- Procedural success is now prioritized over broad toxicity assessments for embolic agents.
- Enhanced neurophysiological understanding aids in optimizing treatment strategies.
Conclusions:
- Modern intravascular interventions prioritize specific embolic agent selection for targeted neurovascular treatments.
- The field has moved towards application-specific evaluations of embolic materials, rather than general dose-response studies.
- Continued innovation in materials and understanding of neurophysiology are key to improving outcomes in treating aneurysms, fistulas, and malformations.